Dual Therapy for Myopia Control

• June 4, 2026

Systemic factors associated with poor anatomical response to anti-VEGF therapy in patients with diabetic macular edema: evidence from a large clinical cohort

• by Xinru Jia, Yan Shi, Mengxiang He, Dongwei Yao, Chengfei Lin

• July 21, 2026

What Retina Specialists Have Learned From TRUCKEE

Carl J. Danzig, MD, reviews 4.5 years of real-world findings showing sustained anatomic improvements, longer treatment intervals, and a favorable safety profile with faricimab in neovascular AMD.

• by Carl Danzig, MD

• July 15, 2026

• 3 min

Expanding Optogenetics to Geographic Atrophy

Jordi Monés, MD, PhD, discusses the rationale for evaluating MCO-010 (sonpiretigene isteparvovec) in GA following encouraging findings in retinitis pigmentosa and Stargardt disease.

• by Jordi Monés, MD, PhD

• July 15, 2026

• 2 min